Increased Psoriasis Risk Seen in Cancer Patients Taking Immune Checkpoint Inhibitors
Patients with cancer who receive immune checkpoint inhibitors (ICIs) have more than twice the risk of developing new-onset psoriasis than their counterparts who receive other cancer therapies, new research in JAMA Dermatology shows. For the study, researchers tapped into data from the Taiwan National Health Insurance database and the Taiwan Cancer Registry. Study participants included […]